Actively Recruiting
A Research Study on How Well Different Doses of the Medicine UBT251 Help People Living With Overweight or Obesity
Led by Novo Nordisk A/S · Updated on 2026-04-21
333
Participants Needed
3
Research Sites
54 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this clinical study is to find out if UBT251 is safe and effective for treating people who are living with overweight or obesity. Participants will get either UBT251 (the treatment being tested) or Placebo (a treatment that has no active medicine in it), which treatment participants get is decided by chance.
CONDITIONS
Official Title
A Research Study on How Well Different Doses of the Medicine UBT251 Help People Living With Overweight or Obesity
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or female (sex at birth)
- For Part C: Japanese, Chinese or non-Asian participants (all self-reported) with both parents of respective descent
- Age 18 to 55 years for Part A and C, 18 to 65 years for Part B
- BMI between 27.0-39.9 kg/m2 for Part A, 30.0-50.0 kg/m2 for Part B, and 24-34.9 kg/m2 for Part C
- Eligible based on medical history, physical exam, vital signs, ECG, and lab tests as judged by the investigator
You will not qualify if you...
- Known or suspected hypersensitivity to study interventions or related products
- Treatment with any marketed product containing GLP-1, GIP, or glucagon receptor agonists within 90 days before screening
- Any condition, unwillingness, or inability that might jeopardize safety or protocol compliance as judged by the investigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
Altasciences Clinical LA, Inc.
Cypress, California, United States, 90630
Actively Recruiting
2
Altasciences Clinical Kansas, Inc.
Overland Park, Kansas, United States, 66212
Actively Recruiting
3
Altasciences Clinical Company, Inc
Montreal, Quebec, Canada, H3P 3P1
Actively Recruiting
Research Team
N
Novo Nordisk
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
11
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here